Aug 25, 2023
Ensuring Evidence-Based Medicine Is Reflected in Coding and Reimbursement: An Update From ASCO’s Advisor to the AMA CPT Editorial Panel
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
Aug 23, 2023
What to Expect After Submitting Your Fellowship Application: Tips for Hematology-Oncology Fellowship Application From Current Fellows
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
Aug 17, 2023
Advanced Practice Providers (APPs) Are Essential to Continuity of Cancer Care, Especially in Rural Communities
"Oncologists and APPs working together have the opportunity to increase practice volume, improve access to care, and ensure continuity for the patient," said Whitney Pritham.
Aug 09, 2023
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center.
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Feb 02, 2023
As we acknowledge World Cancer Day on February 4, Dr. Julie R. Gralow shares how ASCO is engaging members in different regions of the world, "uniting our voices and taking action," through its regional councils.
Nov 10, 2022
ASCO president Dr. Eric P. Winer and Nominating Committee chair Dr. Beverly S. Mitchell call upon all eligible voters to make their voices heard in the ASCO election.
Nov 03, 2021
ASCO president Dr. Everett E. Vokes and Nominating Committee chair Dr. Sharon H. Giordano have a call to action for all voting-eligible members.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.